Concepedia

Author

D. Paillotin

Centre Hospitalier Régional Universitaire de Brest

Also Known As

D Paillotin, D. Paillotin, Dominique Paillotin

41

Publications

827

Citations

10

H-Index

17

Concepts

All Affiliations

Centre Hospitalier Régional Universitaire de BrestCentre Hospitalier Universitaire de RouenCentre Hospitalier Universitaire de RennesCentre Hospitalier Universitaire de LimogesSorbonne Université
DP

About

D. Paillotin is an author at Centre Hospitalier Régional Universitaire de Brest specializing in radiation oncology, oncology, and lung cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

696

2

Health Sciences

7

7

662

3

Pathology

1

1

21

4

Pharmacology

1

1

40

5

Radiation Medicine

1

1

24

D. Paillotin

×

10

Publications

761

Citations

10

H-Index

YearCitations

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1

G. Robinet, P. Thomas, Jean-Luc Breton,

Annals of Oncology

2001

266

Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)

Fabrice Barlési, R. Gervais, H. Léna,

Annals of Oncology

2011

245

A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma

B Lebeau, T. Urban, Jeanne-Marie Br�chot,

Cancer

1999

65

Phase II Trial of Paclitaxel and Carboplatin in Metastatic Small-Cell Lung Cancer: A Groupe Français de Pneumo-Cancérologie Study

P. Thomas, O. Castelnau, D. Paillotin,

Journal of Clinical Oncology

2001

40

Cost-Effectiveness of Second-Line Chemotherapy for Non-small Cell Lung Cancer: An Economic, Randomized, Prospective, Multicenter Phase III Trial Comparing Docetaxel and Pemetrexed: The GFPC 05-06 Study

A. Vergnenègre, R. Corre, H. Bérard,

Journal of Thoracic Oncology

2010

36

Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer

M. Pérol, J C Guérin, P. Thomas,

Lung Cancer

1996

30

Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC – IFCT 02-01

P. Fournel, A. Vergnenègre, G. Robinet,

European Journal of Cancer

2015

24

Prognostic Significance of Supraclavicular Lymph Nodes in Small Cell Lung Cancer

T. Urban, C Chastang, F. Vaylet,

CHEST Journal

1998

21

An open multicenter phase II trial of docetaxel–gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): The GFPC 02-02a study

H. Lecaer, P. Fournel, H. Jullian,

Critical Reviews in Oncology/Hematology

2007

21

Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer

A. Vergnenègre, Casey L. Daniel, H. Léna,

Lung Cancer

2004

13

Page 1